These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9413271)
1. Association of autonomic nervous hyperreflexia and systemic inflammation in patients with Crohn's disease and ulcerative colitis. Straub RH; Antoniou E; Zeuner M; Gross V; Schölmerich J; Andus T J Neuroimmunol; 1997 Dec; 80(1-2):149-57. PubMed ID: 9413271 [TBL] [Abstract][Full Text] [Related]
2. [Cardiovascular and pupillary autonomic and somatosensory neuropathy in chronic diseases with autoimmune phenomena. A comparative study of patients with Crohn disease, ulcerative colitis, systemic lupus erythematosus, progressive systemic sclerosis and type I diabetes mellitus]. Straub RH; Andus T; Lock G; Zeuner M; Palitzsch KD; Gross V; Lang B; Schölmerich J Med Klin (Munich); 1997 Nov; 92(11):647-53. PubMed ID: 9480395 [TBL] [Abstract][Full Text] [Related]
3. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. Halling ML; Kjeldsen J; Knudsen T; Nielsen J; Hansen LK World J Gastroenterol; 2017 Sep; 23(33):6137-6146. PubMed ID: 28970729 [TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing factor modulates cardiovascular and pupillary autonomic reflexes in man: is there a link to inflammation-induced autonomic nervous hyperreflexia? Pongratz G; Zietz B; Glück T; Schölmerich J; Straub RH Ann N Y Acad Sci; 2002 Jun; 966():373-83. PubMed ID: 12114295 [TBL] [Abstract][Full Text] [Related]
5. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Wehkamp J; Harder J; Weichenthal M; Mueller O; Herrlinger KR; Fellermann K; Schroeder JM; Stange EF Inflamm Bowel Dis; 2003 Jul; 9(4):215-23. PubMed ID: 12902844 [TBL] [Abstract][Full Text] [Related]
6. Autonomic dysfunctions in patients with inflammatory bowel disease in clinical remission. Sharma P; Makharia GK; Ahuja V; Dwivedi SN; Deepak KK Dig Dis Sci; 2009 Apr; 54(4):853-61. PubMed ID: 18712478 [TBL] [Abstract][Full Text] [Related]
7. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia. Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184 [TBL] [Abstract][Full Text] [Related]
8. Association of pupillary parasympathetic hyperreflexia and systemic inflammation in patients with systemic lupus erythematosus. Straub RH; Glück T; Zeuner M; Schölmerich J; Lang B Br J Rheumatol; 1998 Jun; 37(6):665-70. PubMed ID: 9667622 [TBL] [Abstract][Full Text] [Related]
9. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Isene R; Bernklev T; Høie O; Munkholm P; Tsianos E; Stockbrügger R; Odes S; Palm Ø; Småstuen M; Moum B; Scand J Gastroenterol; 2015 Mar; 50(3):300-5. PubMed ID: 25535653 [TBL] [Abstract][Full Text] [Related]
10. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. Zippi M; Corrado C; Pica R; Avallone EV; Cassieri C; De Nitto D; Paoluzi P; Vernia P World J Gastroenterol; 2014 Dec; 20(46):17463-7. PubMed ID: 25516659 [TBL] [Abstract][Full Text] [Related]
11. Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease. Strisciuglio C; Bellini G; Miele E; Martinelli M; Cenni S; Tortora C; Tolone C; Miraglia Del Giudice E; Rossi F J Clin Gastroenterol; 2018; 52(5):e37-e43. PubMed ID: 27875353 [TBL] [Abstract][Full Text] [Related]
12. Ulcerative Colitis and Crohn's Disease Are Associated with Decreased Serum Selenium Concentrations and Increased Cardiovascular Risk. Castro Aguilar-Tablada T; Navarro-Alarcón M; Quesada Granados J; Samaniego Sánchez C; Rufián-Henares JÁ; Nogueras-Lopez F Nutrients; 2016 Dec; 8(12):. PubMed ID: 27916926 [TBL] [Abstract][Full Text] [Related]
13. Autonomic cardiovascular regulation in quiescent ulcerative colitis and Crohn's disease. Coruzzi P; Castiglioni P; Parati G; Brambilla V; Brambilla L; Gualerzi M; Cademartiri F; Franzè A; De Angelis G; Di Rienzo M; Di Mario F Eur J Clin Invest; 2007 Dec; 37(12):964-70. PubMed ID: 18036030 [TBL] [Abstract][Full Text] [Related]
14. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. Lakatos L; Pandur T; David G; Balogh Z; Kuronya P; Tollas A; Lakatos PL World J Gastroenterol; 2003 Oct; 9(10):2300-7. PubMed ID: 14562397 [TBL] [Abstract][Full Text] [Related]
15. Endothelial function and cardiovascular risk in active inflammatory bowel diseases. Principi M; Mastrolonardo M; Scicchitano P; Gesualdo M; Sassara M; Guida P; Bucci A; Zito A; Caputo P; Albano F; Ierardi E; Di Leo A; Ciccone MM J Crohns Colitis; 2013 Nov; 7(10):e427-33. PubMed ID: 23473915 [TBL] [Abstract][Full Text] [Related]
16. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease. Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573 [TBL] [Abstract][Full Text] [Related]
17. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing. Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482 [TBL] [Abstract][Full Text] [Related]